UniProt ID | YIPF5_HUMAN | |
---|---|---|
UniProt AC | Q969M3 | |
Protein Name | Protein YIPF5 | |
Gene Name | YIPF5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 257 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein. Golgi apparatus, cis-Golgi network membrane Multi-pass membrane protein. Cytoplasmic vesicle, COPII-coated vesicle . Enriched at the endoplasmic reticulum exit sites. Colocalizes with RA |
|
Protein Description | Plays a role in transport between endoplasmic reticulum and Golgi.. | |
Protein Sequence | MSGFENLNTDFYQTSYSIDDQSQQSYDYGGSGGPYSKQYAGYDYSQQGRFVPPDMMQPQQPYTGQIYQPTQAYTPASPQPFYGNNFEDEPPLLEELGINFDHIWQKTLTVLHPLKVADGSIMNETDLAGPMVFCLAFGATLLLAGKIQFGYVYGISAIGCLGMFCLLNLMSMTGVSFGCVASVLGYCLLPMILLSSFAVIFSLQGMVGIILTAGIIGWCSFSASKIFISALAMEGQQLLVAYPCALLYGVFALISVF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | SGFENLNTDFYQTSY CCCCCCCCCCEECCC | 30.56 | 28348404 | |
12 | Phosphorylation | ENLNTDFYQTSYSID CCCCCCCEECCCCCC | 17.43 | 28348404 | |
14 | Phosphorylation | LNTDFYQTSYSIDDQ CCCCCEECCCCCCCC | 20.46 | 28348404 | |
15 | Phosphorylation | NTDFYQTSYSIDDQS CCCCEECCCCCCCCC | 11.02 | 28348404 | |
16 | Phosphorylation | TDFYQTSYSIDDQSQ CCCEECCCCCCCCCC | 17.03 | 28348404 | |
17 | Phosphorylation | DFYQTSYSIDDQSQQ CCEECCCCCCCCCCC | 21.22 | 28348404 | |
22 | Phosphorylation | SYSIDDQSQQSYDYG CCCCCCCCCCCCCCC | 36.86 | 28348404 | |
25 | Phosphorylation | IDDQSQQSYDYGGSG CCCCCCCCCCCCCCC | 16.60 | 28348404 | |
26 | Phosphorylation | DDQSQQSYDYGGSGG CCCCCCCCCCCCCCC | 14.62 | 28348404 | |
28 | Phosphorylation | QSQQSYDYGGSGGPY CCCCCCCCCCCCCCC | 18.36 | - | |
35 | Phosphorylation | YGGSGGPYSKQYAGY CCCCCCCCCCCCCCC | 31.60 | 25884760 | |
37 | Ubiquitination | GSGGPYSKQYAGYDY CCCCCCCCCCCCCCC | 41.29 | - | |
39 | Phosphorylation | GGPYSKQYAGYDYSQ CCCCCCCCCCCCCCC | 13.01 | 21945579 | |
42 | Phosphorylation | YSKQYAGYDYSQQGR CCCCCCCCCCCCCCC | 11.97 | 21945579 | |
44 | Phosphorylation | KQYAGYDYSQQGRFV CCCCCCCCCCCCCCC | 10.41 | 21945579 | |
45 | Phosphorylation | QYAGYDYSQQGRFVP CCCCCCCCCCCCCCC | 17.09 | 21945579 | |
67 | Phosphorylation | QPYTGQIYQPTQAYT CCCCCCCCCCCCCCC | 10.68 | - | |
77 | Phosphorylation | TQAYTPASPQPFYGN CCCCCCCCCCCCCCC | 25.85 | 26657352 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of YIPF5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of YIPF5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of YIPF5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AT1A1_HUMAN | ATP1A1 | physical | 26496610 | |
ATPA_HUMAN | ATP5A1 | physical | 26496610 | |
ATPB_HUMAN | ATP5B | physical | 26496610 | |
ATPO_HUMAN | ATP5O | physical | 26496610 | |
CAV1_HUMAN | CAV1 | physical | 26496610 | |
COX5B_HUMAN | COX5B | physical | 26496610 | |
CX6B1_HUMAN | COX6B1 | physical | 26496610 | |
PHB_HUMAN | PHB | physical | 26496610 | |
AAAT_HUMAN | SLC1A5 | physical | 26496610 | |
SSRG_HUMAN | SSR3 | physical | 26496610 | |
STX3_HUMAN | STX3 | physical | 26496610 | |
TAF9_HUMAN | TAF9 | physical | 26496610 | |
CEPT1_HUMAN | CEPT1 | physical | 26496610 | |
YIF1A_HUMAN | YIF1A | physical | 26496610 | |
PHB2_HUMAN | PHB2 | physical | 26496610 | |
TMCO1_HUMAN | TMCO1 | physical | 26496610 | |
MPP8_HUMAN | MPHOSPH8 | physical | 26496610 | |
T161A_HUMAN | TMEM161A | physical | 26496610 | |
MACOI_HUMAN | TMEM57 | physical | 26496610 | |
ELOV5_HUMAN | ELOVL5 | physical | 26496610 | |
MBOA7_HUMAN | MBOAT7 | physical | 26496610 | |
ARI5B_HUMAN | ARID5B | physical | 26496610 | |
YIF1B_HUMAN | YIF1B | physical | 26496610 | |
S38A5_HUMAN | SLC38A5 | physical | 26496610 | |
CAVN3_HUMAN | PRKCDBP | physical | 26496610 | |
CAVN1_HUMAN | PTRF | physical | 26496610 | |
RABL3_HUMAN | RABL3 | physical | 26496610 | |
PTAR1_HUMAN | PTAR1 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-39 AND TYR-44, AND MASSSPECTROMETRY. |